Catalog Advanced Search

Search by Category
Search by Format
Search by Type
Sort By
Search by Favorites
Search by Keyword
Search by Category
Search by Format
Search by Type
Credits Offered
Search in Packages
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Start
End
Search by Favorites
Search by Keyword
Sort By
  • Contains 1 Component(s) Includes a Live Web Event on 05/27/2026 at 12:00 PM (CDT)

    May 27: Case Based Webinar - Part Two

    May 27: Case Based Webinar - Part Two

  • Contains 4 Component(s), Includes Credits

    This session will delve into the evolving landscape of Li-Fraumeni Syndrome (LFS), highlighting how our understanding of this syndrome has changed over time, especially with the advent of multi-gene panel testing.

    Unraveling the Mystery: The Evolving Story of Li-Fraumeni Syndrome Presented by: 1. Lawrence Ingrassia, BA 2. Joshua Schiffman, MD 3. Greg Harper This session will delve into the evolving landscape of Li-Fraumeni Syndrome (LFS), highlighting how our understanding of this syndrome has changed over time, especially with the advent of multi-gene panel testing. Attendees will gain insight into LFS as a spectrum of cancer risks, learn about current medical management guidelines, and discover the latest advancements in research. Lawrence Ingrassia, author of A Fatal Inheritance, will share his personal journey through his family's experience with LFS. The session will also emphasize the critical role of advocacy organizations in supporting families and driving forward research and awareness and hope for the future. Learning Objectives: 1. Summarize the current landscape of LFS including the latest medical management recommendations and advancements in research 2. Identify key lessons from Ingrassia's personal narrative that genetic counselors can apply to their own practice in addressing the complex psychosocial and clinical needs of patients and family members with LFS and other similar hereditary syndromes 3. Describe the important role that patient advocacy groups play in providing patient support and education and promoting research The National Society of Genetic Counselors (NSGC) has authorized National Society of Genetic Counselors (NSGC) to offer up to 1.5 Category 1 contact hours for Unraveling the Mystery: The Evolving Story of Li-Fraumeni Syndrome. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification. Successful Completion: 1. View recording 2. Pass quiz 3. Complete survey

  • Contains 4 Component(s), Includes Credits

    This session will incorporate survivor and bystander story-telling, targeted teaching about OHCA preparedness and legislative advocacy, and sharing of genetic counselors' insights into counseling about OHCA preparedness.

    All Hands on Deck: Increasing the Survival Odds of Out-of-Hospital Cardiac Arrest Presented by: 1. Caitlin Finn, MS, CGC 2. Courtney Gwynne, MS, CGC 3. Rebecca Scott, Esq. 4. Abigail Scott, B.S. Candidate 5. Nadine Channaoui, MS, CGC 6. Kimberly Harmon, MD 7. Chelsea Pappas, MS, CGC 8. Maya del Rosario, MS, CGC Genetic counselors may work with patients at elevated risk for cardiac arrest, yet have no requirements to be trained in use of CPR/AED nor counseling about CPR/AED preparedness with families. Furthermore, anyone could be a bystander to out-of-hospital cardiac arrest (OHCA), a medical crisis that has dismal survival odds of only 10% nationwide. This session will incorporate survivor and bystander story-telling, targeted teaching about OHCA preparedness and legislative advocacy, and sharing of genetic counselors' insights into counseling about OHCA preparedness. Learning Objectives: 1. Summarize the current occurrence and survival rates of out-of-hospital cardiac arrests (OHCA), including related disparities 2. Examine first-hand experiences of OHCA as told by a survivor of OHCA who had genetic predisposition and a bystander 3. Illustrate actions bystanders can take to improve survival of OHCA 4. Identify organizations, initiatives, and legislation aimed at increasing bystander preparedness for OHCA 5. Demonstrate strategies to incorporate CPR/AED preparedness into genetic counseling session The National Society of Genetic Counselors (NSGC) has authorized National Society of Genetic Counselors (NSGC) to offer up to 1.5 Category 1 contact hours for All Hands on Deck: Increasing the Survival Odds of Out-of-Hospital Cardiac Arrest. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification. Successful Completion: 1. View recording 2. Pass quiz 3. Complete survey

  • Contains 4 Component(s), Includes Credits

    We'll engage around how genetic counselors can adapt to new scientific changes and also address how the CURES act and video counseling have changed our practices.

    The ABCs of CAGs-The Changing Landscape of Huntington Disease Genetics Presented by: 1. Martha Nance, MD 2. Mara Sifry, MS, LCGC 3. Wes Solem, ScM, CGC 4. Clare Gibbons, MS, CGC, CCGC A discussion of the current scientific insights around Huntington Disease (HD) and how to incorporate this new information into genetic counseling and testing. We'll engage around how genetic counselors can adapt to new scientific changes and also address how the CURES act and video counseling have changed our practices. Some of the latest research, complex counseling issues around testing, and reproductive issues will also be addressed. A panel discussion with audience to follow presentations. Learning Objectives: 1. Identify the mechanisms involved in the new, complex genetics of Huntington Disease. 2. Recognize how this new understanding around HD genetics will impact current genetic counseling and testing practices. 3. Evaluate different testing processes and how they can be modified to fit the changing landscape around genetic testing. 4. Participants will be able to recognize important themes in genetic counseling and testing for neurodegenerative conditions. 5. Participants will be able to apply knowledge of current research approaches to assist patients to understand how they may contribute to finding treatments for Huntington Disease. The National Society of Genetic Counselors (NSGC) has authorized National Society of Genetic Counselors (NSGC) to offer up to 1.5 Category 1 contact hours for The ABCs of CAGs-The Changing Landscape of Huntington Disease Genetics The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification. Successful Completion: 1. View recording 2. Pass quiz 3. Complete survey

  • Contains 4 Component(s), Includes Credits

    This session will explore the transformative impact of the human pangenome on the future of clinical genetic testing.

    Embracing Genetic Diversity: Why the Human Pangenome Matters for Genetic Counseling Presented by: 1. Katherine Bonini, MS, MA, CGC 2. Karen Miga, PhD 3. Stephanie Malia Fullerton, DPhil This session will explore the transformative impact of the human pangenome on the future of clinical genetic testing. Unlike the current human reference genome—built over 20 years ago using limited samples and outdated technology—the pangenome incorporates hundreds of diverse genomes using advanced long-read sequencing. In this session, attendees will gain a foundational understanding of the pangenome, its key differences from the traditional reference genome, and its clinical implications. We will also cover practical considerations for integrating the pangenome into clinical workflows, evaluate cases in which the pangenome enabled diagnoses missed using the single reference genome, and discuss related ethical issues such as equitable access and responsible data use. Designed for genetic counselors across all specialties, this session will prepare attendees for the integration of the pangenome into clinical practice, ensuring they stay at the forefront of genomic innovation as this advanced resource enhances diagnostics and improves patient outcomes. Learning Objectives: 1. Explain the human pangenome and why it is necessary to address the limitations of the traditional reference genome. 2. Identify ethical issues related to the development and use of the human pangenome, particularly as it relates to better representing global genetic diversity and improving care for underrepresented populations. 3. Identify how the human pangenome will enhance clinical genetic testing practices, including improving diagnostic accuracy and addressing health disparities. The National Society of Genetic Counselors (NSGC) has authorized National Society of Genetic Counselors (NSGC) to offer up to 1 Category 1 contact hours for Embracing Genetic Diversity: Why the Human Pangenome Matters for Genetic Counseling. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification. Successful Completion: 1. View recording 2. Pass quiz 3. Complete survey

  • Contains 4 Component(s), Includes Credits

    Explore how unexpected findings and non-traditional clinical pathways can lead to metabolic diagnoses in this case-based NSGC webinar.

    Explore how unexpected findings and non-traditional clinical pathways can lead to metabolic diagnoses in this case-based NSGC webinar. Through real-world examples, speakers highlight key features of metabolic disorders, diagnostic challenges, and strategies to shorten the diagnostic journey. Attendees will gain practical insights to recognize atypical presentations and improve identification and care for patients with metabolic conditions.

    Presenters: 

    NSGC Metabolic and Lysosomal SIG
    Dawn Laney, MS, CGC
    Kelly Jackson, MS, CGC

    Learning Objectives: 

    1. Review case studies that delineate non-traditional paths to metabolic diagnoses
    2. Understand key features of metabolic diseases that can help lead providers to diagnosis
    3. Consider education for providers along non-traditional pathways that might help decrease the diagnostic odyssey for metabolic conditions

    Continuing Education Unit Approval: 

    The National Society of Genetic Counselors (NSGC) has authorized National Society of Genetic Counselors (NSGC) to offer up to 1 Category 1 contact hours for Serendipity and Coincidence: Non-traditional Routes to Metabolic Diagnosis. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.

    Successful Completion:
    1. View recording
    2. Pass quiz
    3. Complete evaluation

  • Contains 24 Product(s)

    This package includes all 24 webinars, along with CEUs, from NSGC's 2025 Webinar Series in one comprehensive package.

    This package includes all 24 webinars, along with CEUs, from NSGC's 2025 Webinar Series in one comprehensive package.

    Continuing Education Unit Approval: 

    The National Society of Genetic Counselors (NSGC) has authorized National Society of Genetic Counselors (NSGC) to offer Category 1 contact hours for the activities in the 2025 Webinar Series Package. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.

    Successful Completion:
    1. View recording
    2. Pass quiz
    3. Complete evaluation

  • Contains 4 Component(s), Includes Credits

    Join us for an engaging, case-based webinar that brings the realities of genetic counseling into focus through complex, real-world clinical scenarios. In this interactive session, expert genetic counselors will walk through challenging cases that highlight evolving genetic knowledge, nuanced risk assessment, and the counseling strategies needed to support patients facing difficult decisions.

    Join us for an engaging, case-based webinar that brings the realities of genetic counseling into focus through complex, real-world clinical scenarios. In this interactive session, expert genetic counselors will walk through challenging cases that highlight evolving genetic knowledge, nuanced risk assessment, and the counseling strategies needed to support patients facing difficult decisions.

    Presented by: 

    Rozalia Valentine, MS, CGC
    Brettne Frewin Elizabeth Spitzer, PhD
    Kendra Schaa, ScM, CGC
    Laura Godfrey Hendon, MA, MS, LCGC

    Date: March 18, 2026

    Learning Objectives: 

    1. Illustrate the role of a genetic counselor in client-centered decision-making
    2. Demonstrate how genetic counselors fit within the larger healthcare system
    3. Review the wide differential and one center’s testing strategy for fetal cystic hygroma.
    4. Examine the impact of severe intrafamilial variable expressivity in a “lethal” Mendelian disorder on patient expectations and coping.
    5. Assess the limitations of current NMD vs NDD classification frameworks in DYNC1H1-related disorders and their impact on accurate diagnostic prognostication
    6. Integrate patient and caregiver narratives into genetic counseling practice to inform communication, expectation-setting, and support.

    Continuing Education Unit Approval: 

    The National Society of Genetic Counselors (NSGC) has authorized National Society of Genetic Counselors (NSGC) to offer up to 1 Category 1 contact hours for NSGC Case Based Webinar - Part One. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.

    Successful Completion:

    1. View recording
    2. Pass quiz
    3. Complete evaluation

  • Contains 4 Component(s), Includes Credits

    Join the genetic counseling champions behind the NSGC Cancer Business Case Toolkit for an in-depth discussion of its development, strategic framework, and practical applications. This session will explore how the toolkit was created, how it can be effectively leveraged within your institution, and how its principles can inform the development of a compelling business case to integrate a genetic counselor into your practice.

    Join the genetic counseling champions behind the NSGC Cancer Business Case Toolkit for an in-depth discussion of its development, strategic framework, and practical applications. This session will explore how the toolkit was created, how it can be effectively leveraged within your institution, and how its principles can inform the development of a compelling business case to integrate a genetic counselor into your practice.

    Presented by:

    Allison Harvey, MPH, CHES, Rhizome
    Sara Pirzadeh-Miller, MS, CGC
    Jaime Grund, MS, LGC
    Stephanie Cohen, MS, LCGC
    Charlie King, MGC, CGC
    Kristen Shannon, MS, LCGC
    Scott M. Weissman, MS, CGC

    Date: March, 16 2026

    Learning Objectives:

    1. Describe the core elements of the NSGC Business Case Toolkit for oncology genetic counseling services.
    2. Describe how toolkit elements can be applied to your practice
    3. Recognize the importance of clinical, financial, and operational metrics in developing a sustainable oncology genetics program

    Continuing Education Unit Approval: 

    The National Society of Genetic Counselors (NSGC) has authorized National Society of Genetic Counselors (NSGC) to offer up to 1 Category 1 contact hours for Making the Case: A Business Toolkit for Expanding Genetic Counseling in Oncology. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.

    Successful Completion:

    1. View recording
    2. Pass quiz
    3. Complete evaluation

  • Contains 4 Component(s), Includes Credits

    This webinar equips genetic counselors and healthcare professionals with practical knowledge to navigate hereditary thoracic aortic disease across diverse clinical settings.

    This webinar equips genetic counselors and healthcare professionals with practical knowledge to navigate hereditary thoracic aortic disease across diverse clinical settings. Emphasis is placed on the clinical significance of these conditions, relevant practice guidelines, their contribution to sudden cardiac death, and current as well as emerging innovations that inform patient care. 

    Presented by: 

    NSGC Cardiogenetics SIG
    Christina Rigelsky, MS, CGC
    Erin Demo, MS, CGC
    Gretchen MacCarrick, MS, CGC 

    Date: September 10, 2025 

    Learning Objectives: 

    1. Identify relevant guidelines for aortic disease.
    2. Recognize the genetic basis of syndromic and non-syndromic hereditary thoracic aortic disease.
    3. List medication and surgical innovations for individuals with hereditary thoracic aortic disease. 

    Continuing Education Unit Approval: 

    The National Society of Genetic Counselors (NSGC) has authorized National Society of Genetic Counselors (NSGC) to offer up to 1 Category 1 contact hours for Aorta University 101, 201, 301. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification. 

    Successful Completion: 

    1. View recording
    2. Pass quiz
    3. Complete evaluation